Published in J Clin Oncol on August 15, 2004
Outcome-Relevant Effects of Shared Decision Making. Dtsch Arztebl Int (2015) 1.63
The role of doctor's opinion in shared decision making: what does shared decision making really mean when considering invasive medical procedures? Health Expect (2005) 1.34
Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychol (2009) 1.30
Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psychooncology (2009) 1.17
Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial. Med Decis Making (2010) 1.03
Enhanced counselling for women undergoing BRCA1/2 testing: Impact on knowledge and psychological distress-results from a randomised clinical trial. Psychol Health (2010) 0.96
Patterns of responses on health-related quality of life questionnaires among patients with HIV/AIDS. J Gen Intern Med (2006) 0.94
New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res (2010) 0.92
An evaluation of two decision-making scales for children with life-limiting illnesses. Palliat Med (2009) 0.91
Development of a personalized decision aid for breast cancer risk reduction and management. BMC Med Inform Decis Mak (2014) 0.86
Recommendations for Providers on Person-Centered Approaches to Assess and Improve Medication Adherence. J Gen Intern Med (2017) 0.82
Development and evaluation of a decision aid for BRCA carriers with breast cancer. J Genet Couns (2011) 0.82
Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation. J Genet Couns (2013) 0.79
Does implementing a development plan for user participation in a mental hospital change patients' experience? A non-randomized controlled study. Health Expect (2013) 0.76
Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support. Healthcare (Basel) (2016) 0.75
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs. Arthritis Res Ther (2016) 0.75
Improving Decision Making about Genetic Testing in the Clinic: An Overview of Effective Knowledge Translation Interventions. PLoS One (2016) 0.75
Decision making for breast cancer prevention among women at elevated risk. Breast Cancer Res (2017) 0.75
Physician trust moderates the relationship between intolerance of uncertainty and cancer worry interference among women with Lynch syndrome. J Behav Med (2016) 0.75
[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]. Ned Tijdschr Geneeskd (2005) 5.28
Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet (1995) 3.61
The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ (2006) 3.27
Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res (2004) 2.80
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet (2005) 2.65
Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet (2012) 2.06
Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients. Eur J Radiol (2013) 2.06
Women worried about their familial breast cancer risk--a study on genetic advice in general practice. Fam Pract (1997) 1.86
Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am J Hum Genet (2000) 1.80
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer (2009) 1.75
Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet (1995) 1.63
Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet (2001) 1.61
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet (2002) 1.57
Cartilage hair hypoplasia, metaphyseal chondrodysplasia type McKusick: description of seven patients and review of the literature. Am J Med Genet (1991) 1.55
Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke (1993) 1.49
Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet (2000) 1.47
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet (1999) 1.46
Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer (2006) 1.45
Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers. Maturitas (2010) 1.43
Determination of a maximum number of artificial inseminations by donor children per sperm donor. Fertil Steril (1995) 1.39
Burnout, engagement and resident physicians' self-reported errors. Psychol Health Med (2009) 1.38
Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet (2005) 1.38
Cost effectiveness of a new strategy to identify HNPCC patients. Gut (2005) 1.38
Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol (2004) 1.36
Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord (1999) 1.32
Quality of life after prostate cancer treatments in patients comparable at baseline. Br J Cancer (2013) 1.31
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet (2010) 1.30
Rett syndrome in adolescent and adult females: clinical and molecular genetic findings. Am J Med Genet A (2003) 1.30
Expanding the clinical and neuroradiologic phenotype of primary microcephaly due to ASPM mutations. Neurology (2009) 1.19
Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer. Br J Cancer (2007) 1.16
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12
Rett syndrome in females with CTS hot spot deletions: a disorder profile. Am J Med Genet A (2005) 1.11
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice. Br J Cancer (2003) 1.08
Georg Schmorl on trophoblasts in the maternal circulation. Placenta (2006) 1.08
Two cases of maternal uniparental disomy 14 with a phenotype overlapping with the Prader-Willi phenotype. Am J Med Genet (1999) 1.07
ICF syndrome: a new case and review of the literature. Hum Genet (1994) 1.04
Duplication of chromosome region 8p23.1-->p23.3: a benign variant? Am J Med Genet (2000) 1.04
Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. Br J Cancer (2004) 1.04
BRCA1 in the family: a case description of the psychological implications. Am J Med Genet (1997) 1.03
Prenatal diagnosis of fragile X syndrome. Lancet (1996) 1.03
Congenital abnormalities reported in Pelger-Huët homozygosity as compared to Greenberg/HEM dysplasia: highly variable expression of allelic phenotypes. J Med Genet (2003) 1.01
The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) (1992) 1.00
Pseudoautosomal inheritance of Léri-Weill syndrome: what does it mean? Clin Genet (2011) 1.00
Physical functioning and quality of life after cancer rehabilitation. Int J Rehabil Res (2004) 0.98
Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet A (2004) 0.98
Perceived barriers to elective single embryo transfer among IVF professionals: a national survey. Hum Reprod (2008) 0.98
An Xp22.1-p22.2 YAC contig encompassing the disease loci for RS, KFSD, CLS, HYP and RP15: refined localization of RS. Eur J Hum Genet (1996) 0.97
Burnout among Dutch medical residents. Int J Behav Med (2007) 0.97
Refinement of the chromosome 16 locus for benign familial infantile convulsions. Clin Genet (2005) 0.96
Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer (2005) 0.96
Family functioning and adolescents' emotional and behavioral problems: when a parent has cancer. Ann Oncol (2007) 0.95
Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome. Leukemia (2009) 0.94
After the introduction into the national newborn screening program: who is receiving genetic counseling for hemoglobinopathies in the Netherlands? Public Health Genomics (2013) 0.93
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC). Fam Cancer (2001) 0.93
A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients. Breast Cancer Res Treat (2011) 0.93
Cerebellar and brainstem hypoplasia in a child with a partial monosomy for the short arm of chromosome 5 and partial trisomy for the short arm of chromosome 10. Neuropediatrics (1995) 0.93
Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results. Clin Genet (2010) 0.92
Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis. Clin Genet (2004) 0.92
Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial. Virchows Arch (2010) 0.92
Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences. Br J Cancer (2002) 0.91
PIK3R1 mutations in SHORT syndrome. Clin Genet (2013) 0.91
Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability. Br J Cancer (2006) 0.90
Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology (2011) 0.90
Do cancer and treatment type affect distress? Psychooncology (2012) 0.90
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet (2005) 0.89
Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy? Clin Genet (2013) 0.89
The quality of communication between parents and adolescent children in the case of parental cancer. Ann Oncol (2005) 0.89
Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI. Eur Radiol (2008) 0.88
Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives. Colorectal Dis (2013) 0.87
One month after diagnosis: quality of life, coping and previous functioning in siblings of children with cancer. Child Care Health Dev (2005) 0.87
Mental retardation and inborn errors of metabolism. J Inherit Metab Dis (2009) 0.87
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res Treat (2006) 0.87
Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity. Leukemia (1997) 0.86
Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distress. Clin Genet (2010) 0.86
Easy-to-use online referral test detects most patients with a high familial risk of colorectal cancer. Colorectal Dis (2014) 0.85
Amniocentesis before 14 completed weeks as an alternative to transabdominal chorionic villus sampling: a controlled trial with infant follow-up. Prenat Diagn (1998) 0.84
Do patients' preferences predict smoking cessation? Prev Med (2005) 0.84
Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome. Eur J Cancer (2011) 0.83
Psychosocial functioning in siblings of paediatric cancer patients one to six months after diagnosis. Eur J Cancer (2003) 0.83
The role of social support in burnout among Dutch medical residents. Psychol Health Med (2007) 0.83
Cataracts, radiculomegaly, septal heart defects and hearing loss in two unrelated adult females with normal intelligence and similar facial appearance: confirmation of a syndrome? Clin Dysmorphol (1996) 0.83
The assessment of genetic risk of breast cancer: a set of GP guidelines. Fam Pract (1999) 0.83
Patients with combined hypercholesterolemia-hypertriglyceridemia show an increased monocyte-endothelial cell adhesion in vitro: triglyceride level as a major determinant. Metabolism (1991) 0.83
Quality of life of survivors of testicular germ cell cancer: a review of the literature. Support Care Cancer (2004) 0.83
5q31 Microdeletions: Definition of a Critical Region and Analysis of LRRTM2, a Candidate Gene for Intellectual Disability. Mol Syndromol (2012) 0.82
Educational-support groups for BRCA mutation carriers satisfy need for information but do not affect emotional distress. Genet Couns (2010) 0.82